Chemoablation with UGN-102 in intermediate-risk non-muscle invasive bladder cancer, are we there yet?

Transl Androl Urol. 2024 Apr 30;13(4):639-642. doi: 10.21037/tau-23-563. Epub 2024 Apr 3.

Authors

Daniel A González-Padilla¹, José Daniel Subiela², Felipe Villacampa-Aubá¹

Affiliations

¹ Department of Urology, Clínica Universidad de Navarra, Madrid, Spain.
² Department or Urology, Hospital Universitario Ramón y Cajal, IRYCIS, Universidad de Alcalá, Madrid, Spain.

No abstract available

Keywords: Bladder cancer; UGN-102; ablation; chemoablation; urothelial carcinoma.

Publication types

Editorial
Comment